DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,196 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $37,240 | -0.2% | 149,049 | -0.2% | 0.06% | -4.8% |
Q1 2024 | $37,304 | +7.9% | 149,384 | +0.0% | 0.06% | -1.6% |
Q4 2023 | $34,557 | -2.7% | 149,379 | +4.3% | 0.06% | -14.9% |
Q3 2023 | $35,533 | +1.1% | 143,221 | -2.2% | 0.07% | +4.2% |
Q2 2023 | $35,135 | -4.4% | 146,394 | +0.4% | 0.07% | -7.8% |
Q1 2023 | $36,753 | -3.2% | 145,823 | +1.9% | 0.08% | -15.4% |
Q4 2022 | $37,971 | -99.9% | 143,061 | +2.9% | 0.09% | -2.2% |
Q3 2022 | $35,897,000 | +2.7% | 138,982 | +0.8% | 0.09% | +2.2% |
Q2 2022 | $34,958,000 | -8.1% | 137,891 | +6.4% | 0.09% | +4.6% |
Q1 2022 | $38,025,000 | -8.7% | 129,634 | +2.4% | 0.09% | -7.4% |
Q4 2021 | $41,646,000 | +15.0% | 126,581 | +6.4% | 0.09% | +3.3% |
Q3 2021 | $36,210,000 | +21.7% | 118,940 | +7.3% | 0.09% | +19.7% |
Q2 2021 | $29,748,000 | +33.7% | 110,854 | +12.2% | 0.08% | +20.6% |
Q1 2021 | $22,244,000 | +0.2% | 98,828 | -1.1% | 0.06% | -6.0% |
Q4 2020 | $22,192,000 | +14.2% | 99,904 | +10.7% | 0.07% | +1.5% |
Q3 2020 | $19,433,000 | +25.8% | 90,250 | +3.3% | 0.07% | +13.8% |
Q2 2020 | $15,442,000 | +24.6% | 87,331 | -2.5% | 0.06% | 0.0% |
Q1 2020 | $12,397,000 | -9.2% | 89,574 | +0.7% | 0.06% | +11.5% |
Q4 2019 | $13,656,000 | +2.0% | 88,976 | -4.0% | 0.05% | -8.8% |
Q3 2019 | $13,383,000 | +0.8% | 92,662 | -0.2% | 0.06% | -1.7% |
Q2 2019 | $13,274,000 | +25.3% | 92,877 | +15.7% | 0.06% | +18.4% |
Q1 2019 | $10,595,000 | +27.5% | 80,258 | -0.4% | 0.05% | +11.4% |
Q4 2018 | $8,308,000 | +11.7% | 80,567 | +17.6% | 0.04% | +22.2% |
Q3 2018 | $7,441,000 | +14.5% | 68,482 | +3.9% | 0.04% | +5.9% |
Q2 2018 | $6,501,000 | -6.8% | 65,884 | -7.6% | 0.03% | -10.5% |
Q1 2018 | $6,978,000 | +6.1% | 71,279 | +0.6% | 0.04% | +5.6% |
Q4 2017 | $6,577,000 | – | 70,853 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |